Company: BDRX
Filing Date: 2025-04-11
Form Type: 20-F
Source: 0001214659-25-005742
Chunk: 64

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-11
Form: 20-F
Item: Item 19
Chunk 64
---
 useful life, for example goodwill, or intangible assets
not ready for use, such as IPRD, are not subject to amortisation and are tested annually for impairment. Assets that are subject to amortisation
are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment
loss is recognised for the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is
the higher of an asset’s fair value less costs to sell and value in use. The reversal of any impairment charge is limited to the
carrying amount of the asset that would have been determined (net of amortisation or depreciation) had no impairment charge been recognised
for the asset in prior periods.

For the purposes of assessing impairment, assets are grouped at the lowest levels
for which there are separately identifiable cash flows (cash-generating units). The Group at 31 December 2024 had two cash generating
units(2023: one, 2022: one) as disclosed in note11. Non-financial assets other than goodwill
that suffered impairment are reviewed for possible reversal of impairment at each reporting date.

Patents
and trademarks

The costs incurred in establishing patents and trademarks are either expensed in
accordance with the corresponding treatment of the development expenditure for the product to which they relate or capitalised if the
development expenditure to which they relate has reached the point of capitalisation as an intangible asset.

Foreign
currency

Transactions entered into by Group entities in a currency other than the currency
of the primary economic environment, in which they operate, are recorded at the rates ruling when the transactions occur. Foreign currency
monetary assets and liabilities are translated at the rates ruling at the reporting date. Exchange differences arising on the retranslation
of unsettled monetary assets and liabilities are recognised immediately in profit or loss.

The presentational currency of the Group is Pounds Sterling. Foreign subsidiaries
use the local currencies of the country where they operate. On consolidation, the results of overseas operations are translated into Pounds
Sterling at rates approximating to those ruling when the transactions took place. All assets and liabilities of overseas operations, including
goodwill arising on the acquisition of those operations, are translated at the rate ruling at the reporting date. Exchange differences
arising on translating the opening net assets at opening rate and the results of overseas operations at actual rate are recognised in
other comprehensive income and accumulated in the foreign exchange reserve.

Exchange differences recognised in